Related Experiment Video
Updated: Jul 6, 2026

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
Published on: October 30, 2013
MUC4 interacts with ErbB2 in human gallbladder carcinoma: potential pathobiological implications.
Naoki Miyahara1, Junichi Shoda, Kazunori Ishige
1Department of Gastroenterology, Institute of Clinical Medicine, University of Tsukuba Graduate School of Comprehensive Human Sciences, 1-1-1 Tennodai, Tsukuba-shi, Ibaraki 305-8575, Japan.
Muc4 protein interacts with erbB2 (a growth factor receptor) in gallbladder cancer, promoting tumor growth. This interaction activates key signaling pathways, suggesting MUC4 as a potential therapeutic target.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Mucin 4 (MUC4) is implicated in tumor progression.
- The role of MUC4 in gallbladder carcinoma (GBC) and its interaction with erbB2 signaling remains unclear.
Purpose of the Study:
- To investigate MUC4 expression and its interaction with erbB2 signaling in human gallbladder carcinomas.
- To elucidate the functional consequences of MUC4-erbB2 interaction on tumor growth and signaling pathways.
Main Methods:
- Analysis of MUC4 and erbB2 expression in GBC specimens using immunohistochemistry and Western blotting.
- Co-immunoprecipitation assays to confirm MUC4-erbB2 interaction.
- Cell proliferation assays and Western blotting to assess downstream signaling pathway activation (MAPK, Akt, cyclooxygenase-2).
Main Results:
- MUC4 protein and mRNA levels were significantly elevated in GBC tissues compared to normal tissues.
- MUC4 was found to interact with erbB2 on the apical surface of cancerous epithelia.
- This interaction correlated with hyperphosphorylation of erbB2, MAPK, Akt, and overexpression of cyclooxygenase-2.
- MUC4 amplified cell proliferation in response to heregulin by enhancing erbB2 phosphorylation and downstream signaling.
Conclusions:
- MUC4 is upregulated in human gallbladder carcinoma and interacts with erbB2.
- The MUC4-erbB2 interaction contributes to the activation of oncogenic signaling pathways, promoting tumor growth.
- Targeting the MUC4-erbB2 axis may represent a novel therapeutic strategy for gallbladder cancer.
Related Concept Videos
Mitogens and the Cell Cycle
Abnormal Proliferation
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
